Healthcare Press

Bristol’s $250,000 Pill Slows Lung Cancer Growth by Seven Weeks

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 50%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

A Bristol Myers Squibb Co. lung cancer treatment delayed tumor growth by less than seven weeks in a closely watched clinical trial, a disappointing result after the company paid nearly $5 billion to acquire the drug’s owner.

Private Credit Firm Ninepoint Halts Cash Payouts on Three FundsDeere to Dismiss Some Salaried Workers Amid Farm DownturnMacron Gets Debt Reprimand as S&P Hits France With DowngradeFed Likely to Seek More Evidence Despite Cooler Inflation DataCharting the Global Economy: Europe Inflation Picks Up Before ECB MeetingNigerian Lawmakers Seek to Strip Central Bank of Crucial PowersS. Africa Election Results With 55.

Energy Secretary calls for more nuclear power while celebrating US$35 billion Georgia reactorsThe Daily Chase: GDP comes in softer than expectedThe Daily Chase: Strong numbers from RBC, CIBC cap earnings from big banksCan AI-driven efficiencies address Canada's lagging economic productivity?The Daily Chase: Light trading day on holidays in U.S.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Saudi Arabia’s Jada Backs $250 Million Fund in Health-Care PushA unit of Saudi Arabia’s sovereign wealth fund is among investors in TVM Capital Healthcare’s $250 million fund that will focus on the health-care industry in the kingdom.
Source: BNNBloomberg - 🏆 83. / 50 Read more »